Tag Archives: Medical Sciences

Young Blood, Old Soul

We often hear our grandparents telling their stories in those “good old days”. Indeed, who doesn’t want to stay forever young? Humans all experience physical and mental function declines as we are inevitably getting old and a lot of researches have been done so far to solve the mystery of aging. As evidence piles up, scientists say that the fountain of youth may lie in the blood.

Credit: Geralt

Can we reverse aging? Credit: Geralt

A recent paper published on Communications Biology showed a restored cognitive function in old mice after they received bone marrow transplantation from younger mice. They found that the level of a critical chemical, called CCL11, in blood was lowered in young bone marrow recipients mice and therefore reasoned that hematopoietic (blood cell generating) system may play a special part in regulating CCL11. This molecule is thought to have an inhibitory effect on nerve cells regeneration, which is a hallmark of aging.

However, this is not the first study in the field. In fact, discoveries on the rejuvenating power of young blood can be dated back as early as 1970s when scientists surgically connected the blood vessels of two lab mice with different ages so that they could share the same circulating blood. The old mice did become younger in terms of some physiological aspects. And more researches have found similar results and pinned down some critical molecules responsible for aging.

https://youtu.be/yKLlXRjktak

Blood transfusion reverses aging in mice
Credit: GeoBeats News

 

Those findings are very promising in helping us understand the mechanism of aging and develop drugs or therapies to fight some of the age-related disease, such as Alzheimer’s disease, in the future. However, our keenness to stay young has already been taken advantage of by some people. A start-up company in California called Ambrosia charged $8,000 to give clients one-time infusion with blood plasma from young people. Just in last month, FDA stated that “we’re concerned that some patients are being preyed upon by unscrupulous actors touting treatments of plasma from young donors as cures and remedies.” Soon after that, Ambrosia stopped their transfusion treatments.

Indeed, it’s not the time to jump the gun yet. First, those findings in animal models may or may not be applicable to humans yet: we still need more evidence to prove that. Secondly, such treatments are generally beyond the regulation of FDA, and they may bring other risks, such as blood-borne diseases, not to mention the societal consequences. Therefore, it seems we do have a long way to go before we find the real fountain of youth.

Written by Xin Dong

Is Genetic Editing the Future?

Genetic editing, is it good or is it bad?

Many people have been debating about this for a while now. One recent news that came out in November talked about a scientist who genetically edited a pair of twin girls. The scientist, He Jiankui, used CRISPR-Cas9 to edit the babies genome which he claims would allow the babies to have a better resistance to HIV and AIDS.

Human egg cells. Image by Виталий Смолыгин. Retrieved from https://www.publicdomainpictures.net/en/view-image.php?image=42719&picture=cell

What the scientist did was that he disabled the gene, CCR5. This disables the HIV virus from entering the cell because the gene forms a protein pathway. With it disabled the virus cannot get in since there wouldn’t be a pathway. The problem with disabling the gene is that people without this gene has a greater chance of being infected by other viruses.

An image of DNA structure. Image by Виталий Смолыгин. Retrieved from https://www.publicdomainpictures.net/en/view-image.php?image=31530&picture=structure-of-dna

There have been many concerns on how this genetic modification can affect the babies because of the fact that this method hasn’t been truly tested. A professor in the University of Oxford, Julian Savulescu, said, “Gene editing itself is experimental and is still associated with off-target mutations, capable of causing genetic problems early and later in life, including the development of cancer.”

Many people condemned the scientist for his seemingly unethical way of human experimentation. But gene editing has been happening for a while and have been proven to heal genetic diseases, it is just that it hasn’t been experimented enough to know for sure that it is safe to be used on humans. One example would be a team of researchers that was led by Gerald Schwank. They were able to successfully correct the mutated genes in the liver cells of mice thus healing the mice from the metabolic disorder phenylketonuria.  Another example is that gene editing was used to reduce cholesterol levels in mice that were still in their mother’s womb. This is done by targeting the gene that regulates cholesterol. The experiment was successful and the mice born were healthy.

So, would you consider gene editing the future?

This video talks about genome editing using CRISPR-Cas9. Published by McGovern Institute for Brain Research at MIT.

This video is about the scientist, He Jiankui, and his experiment on the two twin girls. Published by The He Lab.

Gloria Chan

Parkinson’s Disease: mystery solved by a protein?

Source: Army US

Parkinson’s disease is a lifelong disease with no cure. According to this website, out of all the diseases associated with the brain, Parkinson’s is the second most common. Parkinson’s is characterized by problems with movement, such as uncontrollable shaking and difficulty walking.

Unexplained Cell Death is the cause of Parkinson’s Disease

On a cellular level, Parkinson’s is the result of nerve cell death. Neurons are the cells that make up our nervous system. Since the nervous system is responsible for our ability to think, feel and move, neurons are pretty important. Especially, since, after a certain age, we stop producing new neurons.

Essentially, Parkinson’s Disease is caused by the massacre of these precious neurons. Specifically, Parkinson’s is caused by the nerve cell death in a specific part of the brain,  the Substantia Nigra. Nerve cells in this region produce dopamine, a chemical signal involved in producing movement.

As of now, we have yet to find a clear culprit responsible for the cell death in Parkinson’s. However, active research has shed some light on the matter.

Relative location of the Substantia Nigra. Source: Wikimedia Commons

Lewy Bodies’ association with Parkinson’s Disease

Lewy bodies are essentially clumps of broken protein, of different types and sizes. According to this study, Lewy bodies are especially common in the dopamine-producing cells belonging to patients with Parkinson’s. Because they have such a strong association with the disease, Lewy Bodies and their protein contents have piqued scientists’ interests.

One protein of note, is alpha-synuclein. In the healthy body, the function of this protein is unknown. In diseased state, however, scientists have found they make up a large portion of Lewy Bodies. With this, we turn to another study that investigated alpha-synuclein’s role in hereditary Parkinson’s Disease.

Example of a Lewy Body (the dark red circle). Source: Wikimedia Commons

Alpha-Synuclein’s role in Hereditary Parkinson’s

There are two broad categories of Parkinson’s: hereditary and non-hereditary. The hereditary type is rare and, like most hereditary disease, the cause can be found in the patient’s genes. Specifically, researchers have found a mutation in the gene that codes for alpha-synuclein. The mutation ended up producing proteins with the wrong shape. The correct proteins should have what is called an alpha helix shape; meanwhile, the defective protein had a beta sheet shape instead (refer to diagram below). Unlike alpha helices, beta sheets have the ability to stack on top of each other to form an amyloid fibril. These structures start to pose a problem because they are hard to degrade and are useless, just hanging around inside the cell. Amyloid fibrils have the potential to kill neurons and explains the cell death seen in this particular type of Parkinson’s.

The researchers for this study feel that the same mutation is probably no the cause for the more common, non-hereditary version of this disease. However, they also feel that a similar process may be at play here and their findings have provided groundwork for future research.

“Vessel Baby” on the Way?

You probably have seen it more than once in Sci-fi movies: human babies are incubated in large fluid-filled vessels growing and waiting to come alive. I am not a big fan of such movies, but a recent study has made those scenes one step closer to reality.

A paper published on Nature  caught public’s attention in 2017. Scientists at the Children’s Hospital of Philadelphia kept eight premature lambs in an “artificial womb” system to allow those lambs to continue growing outside mother lambs’ body up to four weeks. The “artificial womb” looks a lot like a plastic bag filled with solution which mimics amniotic fluid in the real uterus. The baby lamb’s umbilical cord (containing blood vessels) was also connected to a bunch of tubes which provide oxygen and remove carbon dioxide at the same time.

Credit: Nature Communication

Schematic and Real Setup of Artificial Womb

Scientists of this study think such extra-uterine supporting system would be extremely beneficial for preterm human babies in the near future. Statistics show that infants have lower than 50% survival rate and may face lifelong health issues if they are born at or before 25 weeks. It is also one of the leading causes of new-born death and illness in the U.S. “These infants have an urgent need for a bridge between the mother’s womb and the outside world,” says  Alan W. Flake,  also the leading researcher of this study. With “artificial womb” like this, doctors and caregivers could keep a premature baby in a “uterus-like” environment longer enough for its important organs to grow and thus significantly reduces the rate of mortality and the risks of other complications.

Although this technology seems incredibly promising and considered as “a pretty momentous achievement” by  other researchers in the field, some people also raise ethical concerns about it. Can people abort a “vessel baby”? Who is going to raise the baby if both parents abandon it before it is born? They argue if artificial uterus further extends human’s ability to grow embryos and fetuses, such action would challenge our laws around issues like abortion and reproductive rights. However, other people embrace this technology which may become an option for homosexual males to have their own kids without the use of surrogate and allow women to have children without going through painful labour. Fortunately, we probably won’t see human babies “popped” out of such artificial system very soon since scientists need more time to tackle many technical issues and perfect the “womb”. This leaves the general public and policy makers some time to discuss all the ethical and legal considerations behind it.

Xin Dong